Garima Tiwari

Garima Tiwari

Auto-generated profile, based on publicly available information

Garima Tiwari

Pinnacle Medicines US Inc.1980 S. Easton Road, Doylestown, PA 18901

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
GTGarima Tiwari
Garima Tiwari
DMDebasisa Mohanty
Debasisa Mohanty
Inhibitors of PDZ-peptide interactions have important implications in a variety of biological processes including treatment of cancer and Parkinson’s disease. Even though experimental studies have reported characterization of peptidomimetic inhibitors of PDZ-peptide interactions, the binding modes for most of them have not been characterized by structural studies. In this study we have attempted to understand the structural basis of the small molecule-PDZ interactions by in silico analysis of the binding modes and binding affinities of a set of 38 small molecules with known Ki or Kd values for PDZ2 and PDZ3 domains of PSD-95 protein. These two PDZ domains show differential selectivity for these compounds despite having a high degree of sequence similarity and almost identical peptide binding pockets. Optimum binding modes for these ligands for PDZ2 and PDZ3 domains were identified by using a novel combination of semi-flexible docking and explicit solvent molecular dynamics (MD) simulations. Analysis of the binding modes revealed most of the peptidomimectic ligands which had high Ki or Kd moved away from the peptide binding pocket, while ligands with high binding affinities remained in the peptide binding pocket. The differential specificities of the PDZ2 and PDZ3 domains primarily arise from differences in the conformation of the loop connecting βB and βC strands, because this loop interacts with the N-terminal chemical moieties of the ligands. We have also computed the MM/PBSA binding free energy values for these 38 compounds with both the PDZ domains from multiple 5 ns MD trajectories on each complex i.e. a total of 228 MD trajectories of 5 ns length each. Interestingly, computational binding free energies show good agreement with experimental binding free energies with a correlation coefficient of approximately 0.6. Thus our study demonstrates that combined use of docking and MD simulations can help in identification of potent inhibitors of PDZ-peptide complexes.

20 January 2017 in The Journal of Physical Chemistry B
Verified
Journal Article
Closed access
GTGarima Tiwari
Garima Tiwari
CVChandra S Verma
Chandra S Verma

1 February 2016 in Biophysical Journal
Verified
Journal Article
Open access
PDF file
GTGarima Tiwari
Garima Tiwari
CVChandra S Verma
Chandra S Verma

23 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KKKamlesh Kumari
Kamlesh Kumari
SMSanjeet Kumar Mahtha
Sanjeet Kumar Mahtha
MPMegha Parihar
Megha Parihar
GTGarima Tiwari
Garima Tiwari
Gitanjali YadavGitanjali Yadav
Gitanjali Yadav
VGVineet Gaur
Vineet Gaur
SUMMARY: The hydrophobic nature of lipids requires specialized transport mechanisms, and one such non-vesicular transport mechanism involves StAR-related lipid transfer (START) domain proteins. Unlike multidomain variants, plant minimal START proteins remain poorly understood. Integrating structural screening across representative plant species, including Arabidopsis thaliana, Solanum lycopersicum, Cicer arietinum, Glycine max and Oryza sativa , with experimental validation, we show these proteins specifically bind amphipathic lipids, primarily myristic acid and lysophosphatidylcholine. Detailed analysis via circular dichroism, molecular dynamics simulations, and subcellular localization focused on the Arabidopsis protein AT4G14500. Ligand binding occurs through a bipartite mechanism where conserved basic cavity residues coordinate polar headgroups while hydrophobic tails sit deeper within the pocket. Mechanistically, ligand association induces closure of a lid-like β 5 -β 6 loop at the cavity entrance, whereas membrane proximity promotes gate reopening and lipid release, supporting a membrane-guided gating mechanism. Consistent with this model, confocal microscopy revealed AT4G14500 associates with key lipid metabolic sites: the endoplasmic reticulum, plastids, Golgi apparatus, and plasma membrane. Together, our findings establish plant minimal START proteins as bona fide lipid-binding proteins that utilize a bipartite ligand-binding mechanism coupled with membrane-responsive gating dynamics. Abstract Figure: Graphical : Proposed model for ligand binding and membrane-associated gating in plant minimal START proteins . (1) In the apo state, the lid (β 5 –β 6 loop) adopts an open conformation that permits ligand entry into the hydrophobic cavity. (2) Ligand binding induces closure of the lid, resulting in entrapment of the lipid within the START-domain cavity. (3) Membrane proximity promotes reopening of the loop and facilitates lipid release toward the membrane.